Skip to main content
Premium Trial:

Request an Annual Quote

Juergen Schwiezer, Severin Schwan, Franz Humer, David Lester, Michael Mullenix, Gabriella Szekely-Klepser

Jürgen Schwiezer will become CEO of Roche Diagnostics on Jan. 1, 2008. He will succeed Severin Schwan, who will take over the role of CEO of the Roche Group from Franz Humer in March.
Schwiezer is currently president of the Europe, Middle East, and Africa regions for Roche Diagnostics. He joined Boehringer Mannheim in 1976 and held a number of management positions in marketing and sales. That firm was acquired by Roche in 1997.
Schwiezer also will serve on Roche’s corporate executive committee. 

Gene Express has appointed David Lester as senior VP of strategy and corporate development. Lester previously worked as New York site head for Pfizer’s global clinical technology business, and he was founder and director of Pfizer Human Health Technologies.
Lester also was a director of clinical technologies for experimental medicine at Pharmacia, and was a senior service advisor to the Office of Pharmaceutical Sciences and an associate director and team leader at the US Food and Drug Administration

Assay Designs has named Michael Mullenix to the post of VP of research and development and Gabriella Szekely-Klepser as VP of science and technology.
Mullenix previously was at Amgen, where he was principal scientist in clinical immunology, and he has held leadership roles at Molecular Staging, Becton Dickinson, and Strategic Diagnostics.

Szekely-Klepser has been an associate research fellow at Pfizer Global R&D, and she has held various R&D roles at 3M Corporation

Filed under

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.